EFFICACY OF LOW-DOSE INTERLEUKIN 2 AS ADD-ON IN THE TREATMENT OF UNIPOLAR AND BIPOLAR DEPRESSION

被引：0
|
作者：
Poletti, Sara [1 ,2 ]
Zanardi, Raffaella [2 ,3 ]
Mandelli, Alessandra [4 ]
Aggio, Veronica [1 ,2 ]
Finardi, Annamaria [3 ]
Lorenzi, Cristina [1 ]
Borsellino, Giovanna [5 ]
Carminati, Matteo [2 ,3 ]
Manfredi, Elena [2 ,3 ]
Tomasi, Enrico [6 ]
Spadini, Sara [1 ]
Colombo, Cristina [2 ,3 ]
Drexhage, Hemmo [7 ]
Furlan, Roberto [2 ,4 ]
Benedetti, Francesco [1 ,2 ]
机构：
[1] Sci Inst Osped San Raffaele, Div Neurosci, Psychiat & Clin Psychobiol, Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
[3] Sci Inst Osped San Raffaele, Mood Disorder Unit, Milan, Italy
[4] Sci Inst Osped San Raffaele, Inst Expt Neurol, Div Neurosci, Clin Neuroimmunol, Milan, Italy
[5] IRCCS Santa Lucia Fdn, Neuroimmunol Unit, Rome, Italy
[6] Sci Inst Osped San Raffaele, Hosp Pharm, Milan, Italy
[7] Erasmus Univ, Dept Immunol, Med Ctr, Rotterdam, Netherlands
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2025年 / 28卷
关键词：
interleukin; 2; antidepressant; immunopsychiatry; Major depressive disorder; bipolar disorder;
D O I：
10.1093/ijnp/pyae059.086
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
pyae059.08
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Psychedelics in the treatment of unipolar and bipolar depression
    Oliver G. Bosch
    Simon Halm
    Erich Seifritz
    International Journal of Bipolar Disorders, 10
  • [32] Low dose zonisamide treatment for Bipolar Depression
    Anand, A
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S160 - S160
  • [33] Efficacy of low-dose, add-on therapy of clobazam (CLB) is produced by its major metabolite, N-desmethyl-CLB
    Kinoshita, Masako
    Ikeda, Akio
    Begum, Tahamina
    Terada, Kiyohito
    Shibasaki, Hiroshi
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 263 (1-2) : 44 - 48
  • [34] Low-dose mitoxantrone as add-on therapy in multiple sclerosis unresponsive to interferon-beta
    Maimone, Davide
    Bianca, Marco
    Zappala, Giuseppe
    Virzi, Valentina
    Matta, Francesca
    Leonardo, Mario
    NEUROLOGY, 2008, 70 (11) : A93 - A93
  • [35] Low-Dose Interleukin-2 Treatment of Refractory Lupus Nephritis
    Zhang, Xia
    He, Jing
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [36] Low-Dose Interleukin 2 for the Treatment of Moderate to Severe Ulcerative Colitis
    Allegretti, Jessica R.
    Mitsialis, Vanessa
    Canavan, James B.
    Snapper, Scott B.
    GASTROENTEROLOGY, 2023, 165 (02) : 492 - +
  • [37] Low-dose interleukin-2: A potential treatment for pemphigus vulgaris
    Long, Hai
    Liao, Jieyue
    Yang, Miao
    Wang, Xin
    Zhang, Guiying
    Lu, Qianjin
    AUTOIMMUNITY REVIEWS, 2021, 20 (10)
  • [38] Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression: A Multicenter, Double-Blind, Placebo-Controlled Trial
    van der Loos, Marc L. M.
    Mulder, Paul G. H.
    Hartong, Erwin G. Th. M.
    Blom, Marc B. J.
    Vergouwen, Anton C.
    de Keyzer, Herman J. U. E. M.
    Notten, Peter J. H.
    Luteijn, Marijke L.
    Timmermans, Manuela A.
    Nolen, Willem A.
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (02) : 223 - 231
  • [39] LOW-DOSE CYCLOPHOSPHAMIDE AND LOW-DOSE INTERLEUKIN-2 FOR MALIGNANT-MELANOMA
    MITCHELL, MS
    KEMPF, RA
    HAREL, W
    SHAU, H
    BOSWELL, WD
    LIND, S
    DEAN, G
    MOORE, J
    BRADLEY, EC
    BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 1989, 65 (01) : 128 - 144
  • [40] Low-dose interleukin-2 in patients with bipolar depression: A phase 2 randomised double-blind placebo-controlled trial
    Leboyer, Marion
    Foiselle, Marianne
    Tchitchek, Nicolas
    Tamouza, Ryad
    Lorenzon, Roberta
    Richard, Jean-Romain
    Arrouasse, Raphaele
    Le Corvoisier, Philippe
    Le Dudal, Katia
    Vicaut, Eric
    Ellul, Pierre
    Rosenzwajg, Michelle
    Klatzmann, David
    BRAIN BEHAVIOR AND IMMUNITY, 2025, 123 : 177 - 184
12345